CeriBell, Inc. (CBLL)Healthcare | Medical Devices | Sunnyvale, United States | NasdaqGS
21.13 USD
Short-term: ★★★☆☆ | Long-term: ★★★★☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:08 p.m. EDT
Despite the 'Strong Buy' analyst consensus and solid 33% revenue growth, CBLL is not a short-term momentum play; the massive volume of OTM puts suggests a sophisticated hedge against a potential retracement rather than a bullish squeeze. Long-term investors should appreciate the high marginal gross margins and strong cash position, but the near 30% trailing P/S and negative earnings create a volatile trading environment where patience is required. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.106237 |
| MSTL | 0.127802 |
| AutoARIMA | 0.133634 |
| AutoETS | 0.135328 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 57% |
| H-stat | 2.41 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.907 |
| Excess Kurtosis | -0.28 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 14.341 |
| Revenue per Share | 2.437 |
| Market Cap | 795,359,104 |
| Forward P/E | -21.01 |
| Profit Margins | -59.97% |
| Website | https://www.ceribell.com |
As of April 18, 2026, 11:08 p.m. EDT: Options flow shows a distinct 'risk reversal' with heavy out-of-the-money (OTM) put open interest accumulating at significantly lower strikes (2.5, 5.0, 7.5) for the June and May expirations, contrasting with minimal OTM call positioning except for a June 22.5 strike. The near-term April 17 call spread is tight (ATM at 20.0), limiting immediate upside bet size, while put writers are establishing a hedge against a -20% downside. Volatility skew is elevated on deep OTM puts (IV > 19%), indicating market fear regarding a significant drop despite the lack of near-term call speculation.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.43060255 |
| Address1 | 360 North Pastoria Avenue |
| All Time High | 32.749 |
| All Time Low | 10.01 |
| Ask | 27.05 |
| Ask Size | 2 |
| Audit Risk | 4 |
| Average Analyst Rating | 1.1 - Strong Buy |
| Average Daily Volume10 Day | 239,670 |
| Average Daily Volume3 Month | 298,190 |
| Average Volume | 298,190 |
| Average Volume10Days | 239,670 |
| Bid | 15.1 |
| Bid Size | 2 |
| Board Risk | 7 |
| Book Value | 4.144 |
| City | Sunnyvale |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 21.13 |
| Current Ratio | 9.73 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 21.39 |
| Day Low | 21.04 |
| Debt To Equity | 14.341 |
| Display Name | CeriBell |
| Earnings Call Timestamp End | 1,778,531,400 |
| Earnings Call Timestamp Start | 1,778,531,400 |
| Earnings Timestamp | 1,778,529,600 |
| Earnings Timestamp End | 1,778,529,600 |
| Earnings Timestamp Start | 1,778,529,600 |
| Ebitda | -57,061,000 |
| Ebitda Margins | -0.64068 |
| Enterprise To Ebitda | -11.538 |
| Enterprise To Revenue | 7.392 |
| Enterprise Value | 658,374,144 |
| Eps Current Year | -1.45588 |
| Eps Forward | -1.00564 |
| Eps Trailing Twelve Months | -1.46 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 19.1052 |
| Fifty Day Average Change | 2.0247993 |
| Fifty Day Average Change Percent | 0.10598158 |
| Fifty Two Week Change Percent | 43.060257 |
| Fifty Two Week High | 24.33 |
| Fifty Two Week High Change | -3.2000008 |
| Fifty Two Week High Change Percent | -0.1315249 |
| Fifty Two Week Low | 10.85 |
| Fifty Two Week Low Change | 10.279999 |
| Fifty Two Week Low Change Percent | 0.9474653 |
| Fifty Two Week Range | 10.85 - 24.33 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,728,653,400,000 |
| Float Shares | 24,292,896 |
| Forward Eps | -1.00564 |
| Forward P E | -21.011494 |
| Free Cashflow | -23,596,500 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 327 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.87886 |
| Gross Profits | 78,274,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.13362001 |
| Held Percent Institutions | 0.85252 |
| Implied Shares Outstanding | 37,641,229 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California. |
| Market | us_market |
| Market Cap | 795,359,104 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_531649318 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -53,412,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 795,359,168 |
| Number Of Analyst Opinions | 7 |
| Open | 21.2 |
| Operating Cashflow | -40,808,000 |
| Operating Margins | -0.58893 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 800 436 0826 |
| Previous Close | 21.13 |
| Price Eps Current Year | -14.513557 |
| Price Hint | 2 |
| Price To Book | 5.098938 |
| Price To Sales Trailing12 Months | 8.930298 |
| Profit Margins | -0.59971 |
| Quick Ratio | 9.084 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.125 |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 21.39 |
| Regular Market Day Low | 21.04 |
| Regular Market Day Range | 21.04 - 21.39 |
| Regular Market Open | 21.2 |
| Regular Market Previous Close | 21.13 |
| Regular Market Price | 21.13 |
| Regular Market Time | 1,776,783,077 |
| Regular Market Volume | 31,862 |
| Return On Assets | -0.17331 |
| Return On Equity | -0.30829 |
| Revenue Growth | 0.337 |
| Revenue Per Share | 2.437 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 37,641,229 |
| Shares Percent Shares Out | 0.0499 |
| Shares Short | 1,880,159 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,925,021 |
| Short Name | CeriBell, Inc. |
| Short Percent Of Float | 0.075 |
| Short Ratio | 6.18 |
| Source Interval | 15 |
| State | CA |
| Symbol | CBLL |
| Target High Price | 32.0 |
| Target Low Price | 24.0 |
| Target Mean Price | 27.57143 |
| Target Median Price | 28.0 |
| Total Cash | 159,260,992 |
| Total Cash Per Share | 4.231 |
| Total Debt | 22,276,000 |
| Total Revenue | 89,063,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.46 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 16.479725 |
| Two Hundred Day Average Change | 4.6502743 |
| Two Hundred Day Average Change Percent | 0.28218156 |
| Type Disp | Equity |
| Volume | 31,862 |
| Website | https://www.ceribell.com |
| Zip | 94,085 |